Désirée J. Wendering

Statistics

Publications

Citations

593

H-Index

Active since

2018

Affiliations

Berlin Institute of Health at Charité - Universitätsmedizin Berlin(Current)

Charité - Universitätsmedizin Berlin

Berlin-Brandenburger Centrum für Regenerative Therapien

Humboldt-Universität zu Berlin

Einstein Center for Neurosciences Berlin

Désirée J. Wendering is an author at Berlin Institute of Health at Charité - Universitätsmedizin Berlin specializing in immunology, life sciences, and transplant immunotherapy.

ORCID

Publications per year

2018–2024

Publications

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

Dimitrios L. Wagner, Leila Amini, Désirée J. Wendering et al. · Nature Medicine · 2018 · 390 citations

Life Sciences, Immunology, Microbiology +13

CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients

Leila Amini, Dimitrios L. Wagner, Uta Rössler et al. · Molecular Therapy · 2020 · 58 citations · Full text

Life Sciences, Biotechnology, Immunology +17

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients

Sophie Steiner, Franziska Sotzny, Sandra Bauer et al. · Frontiers in Immunology · 2020 · 46 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer

Tino Vollmer, Stephan Schlickeiser, Leila Amini et al. · Science Translational Medicine · 2021 · 45 citations

Medicine, Immunology, Oncology +15

Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

Lena Peter, Désirée J. Wendering, Stephan Schlickeiser et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 20 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

1–5 of 7